Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07106879 · ClinicalTrials.gov registry record
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
A clinical trial of Obesity and Cardiovascular Diseases, sponsored by Clindove Research.
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT07106879: Recruiting study of Obesity and Cardiovascular Diseases, sponsored by Clindove Research.
NCT07106879 is a study of Obesity and Cardiovascular Diseases that is actively recruiting participants, run by Clindove Research. The registered enrollment target is 7,000 participants, above the 812-participant average among 1,053 other Obesity trials with a reported enrollment target (762% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07106879, a study of Obesity and Cardiovascular Diseases, is actively recruiting participants, sponsored by Clindove Research.
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.
Primary Outcome
The number of participants who express interest in industry-sponsored clinical research in each of the following therapeutic areas: cardiovascular, endocrine, metabolic and mental health disorder.
Conditions Studied
Interventions
- OTHER Blood Work
Study Locations (1)
New York
- Clindove Research LLC - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2030-12-01 |
What NCT07106879 shows while recruiting
NCT07106879 is an observational study that tracks outcomes without assigning an intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, above the 812-participant average among 1,053 other Obesity trials with a reported enrollment target (762% higher).
The record links to 8 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Blood Work is the first listed.
NCT07106879 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07106879 about?
NCT07106879 is a clinical study titled "Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.". DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current healt...
What is the current status of trial NCT07106879?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2025-07-30. Estimated completion is 2030-12-01.
What conditions does trial NCT07106879 study?
This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, PreDiabetes, Metabolic Syndrome, Type 2 Diabetes Mellitus (T2DM).
What interventions are being tested in trial NCT07106879?
The interventions under investigation include: Blood Work (OTHER).
Who is sponsoring clinical trial NCT07106879?
This trial is sponsored by Clindove Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07106879 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07106879's enrollment target sits among peer trials
7,000 12th of 1053 higher than 1,042 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI